
BTOG has produced 3 infographics about the NICE Appraisal process suitable for HCPs and patients – unless you are involved in NICE appraisals you may not be familiar with the full process. Learn more btog.org/nice-appraisal-proc… #LCSM #lungcancer

British Thoracic Oncology Group (BTOG) - multi-disciplinary group for professionals involved with thoracic malignancies.

BTOG has produced 3 infographics about the NICE Appraisal process suitable for HCPs and patients – unless you are involved in NICE appraisals you may not be familiar with the full process. Learn more btog.org/nice-appraisal-proc… #LCSM #lungcancer

Could AI help read the cell samples used to diagnose #lungcancer? A new @NatureCancer model was tested on pleural fluid and bronchial brushings. On one fluid dataset, it told cancerous from benign samples with 99.4% accuracy. #LCSM doi.org/10.1038/s43018-026-0…

What if the type of biomarker test you're given could add months to your life? A new JNCCN study of 35,000+ people with advanced #lungcancer found that broad genomic testing before treatment was linked to significantly longer survival, 16 months versus 14. That's exactly the kind of access we need to see for people affected by lung cancer. Full story: lungcancereurope.eu/news/bio…

A new single-cell atlas of non-small-cell #LungCancer found that standard staging alone can get a patient's risk wrong, in both directions. A quarter of people staged as stage I were actually high risk. A small group of stage IV patients had survival as good as early stage disease. This is exactly the point Lung Cancer Europe has long made through its Get Checked! campaign: a stage label is not the whole picture. Full story: lungcancereurope.eu/news/why…

Staging. Pathology. Molecular characteristics. Understanding each piece of the diagnostic picture is essential when discussing an NSCLC patient at MDM. NSCLC Back to Basics will explore how these elements come together and inform the next steps in a patient’s care. 21 January 2027 | Manchester Programme and registration: btog.org/nsclc-back-to-basic…


New to lung cancer care? About to attend your first MDM? Or looking for a practical refresher on the NSCLC pathway? NSCLC Back to Basics brings together experts from across the multidisciplinary team for a one-day introduction to diagnosis, staging and treatment. Join BTOG in Manchester on 21 January 2027. Find out more and register: btog.org/nsclc-back-to-basic…

Just released! Annual conference first release draft programme - faculty invitations in progress. btog.org/25th-btog-annual-co…

This recent review article by @alissajcooper and @sands_jacob discusses the current landscape and future directions of DLL3-targeting T-cell engagers in small cell lung cancer. 🫁 🔗: acsjournals.onlinelibrary.wi… @OncoAlert @DanaFarber @SclcSMASHERS #LCSM #SCLC

Our words matter. Help eliminate stigma in lung cancer. #LCAM #LCSM
How we talk about lung cancer matters. Created by patient advocates to help physicians reduce stigma, IASLC’s language guide can also help you support someone with lung cancer through compassionate words. Download and share: bit.ly/IASLCLangGuide #LCAM

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: @ASCO Living Guideline, Version 2026.3.4. Read the full article. bit.ly/3Uwc3KE #NSCLC #lcsm

Don't just take our word for it – see what delegates said about BTOG 2026! Feedback from this year's BTOG Annual Conference highlights the value of bringing the thoracic oncology community together to share knowledge, discuss developments and learn from one another. ⭐ 95% agreed the conference was relevant to their educational needs. ⭐ 88% agreed they learnt a great deal. ⭐ 76% agreed the conference would change their clinical practice. ⭐ 99.6% agreed the speakers communicated effectively. Swipe through to see more feedback from BTOG 2026! Join us for the 25th BTOG Annual Conference #BTOG27, taking place 3–5 March 2027 at the EICC, Edinburgh, as we continue to advance education, collaboration and excellence in thoracic oncology. Register now: btog.org/25th-btog-annual-co…

This year’s Annual Conference delivered real impact: ✔ Relevant, well-structured education ✔ Clear, effective speakers ✔ Minimal commercial bias ✔ Practice-changing insights We’re building on that feedback for next year. Register now and join us btog.org/25th-btog-annual-co…

The Promise and Challenge of Personalized Lung Cancer Screening. Read the full article. bit.ly/47p9HQP #LungCancer #lcsm

🚨New Simply Oncology Podcast on #LungCancer with the superb @tnewsomdavis -Chair of BTOG🚨 🎙️We look beyond ChemoIO and targeted therapy 🎙️T Cell engagers, ADCs and Bispecifics are all on the menu 🥘 A feast for anyone treating lung cancer💥 @BTOGORG @OncoAlert @LungCancerEu

A confident contribution to the lung cancer MDM starts with understanding how the diagnosis comes together. At BTOG’s NSCLC Back to Basics, our first session explores NSCLC demographics, staging, pathology and molecular characteristics, and how an efficient MDM works. Thursday 21 January 2027 | Manchester View the full programme and register: btog.org/nsclc-back-to-basic… #NSCLC #LungCancer #ThoracicOncology